Yajuan C. Hao

1665 Kongjiang Road
Shanghai, 200092, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 42 publications

m6A RNA modification guides alternative polyadenylation to maintain T cell quiescence.

m6A RNA modification guides alternative polyadenylation to maintain T cell quiescence.

Journal: Science advances

Published: May 13, 2026

ALOX5 mediates sunitinib resistance in renal cell carcinoma by reprogramming lipid metabolism through the p38/ERK/PPARα axis.

ALOX5 mediates sunitinib resistance in renal cell carcinoma by reprogramming lipid metabolism through the p38/ERK/PPARα axis.

Journal: International immunopharmacology

Published: April 14, 2026

Interplay of RNA m6A/m1A/m5C/m7G/ψ Regulators Predicting the Prognosis of Pancreatic Cancer.

Interplay of RNA m6A/m1A/m5C/m7G/ψ Regulators Predicting the Prognosis of Pancreatic Cancer.

Journal: FASEB bioAdvances

Published: November 13, 2025

ADAMTS9-AS2 Disrupts Docetaxel-Resistance in Castration-Resistant Prostate Cancer via Stemness Suppression and Ferroptosis Induction.

ADAMTS9-AS2 Disrupts Docetaxel-Resistance in Castration-Resistant Prostate Cancer via Stemness Suppression and Ferroptosis Induction.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: October 23, 2025

RNA Helicase DDX21 Controls CD4+ T Cell Proliferation and Promotes Inflammatory Bowel Disease via Translational Control.

RNA Helicase DDX21 Controls CD4+ T Cell Proliferation and Promotes Inflammatory Bowel Disease via Translational Control.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: August 27, 2025

PSMD2-Mediated MAPK Signaling Promotes Bladder Cancer Development and Immune Microenvironment Remodeling.

PSMD2-Mediated MAPK Signaling Promotes Bladder Cancer Development and Immune Microenvironment Remodeling.

Journal: Oncology research

Published: August 25, 2025

Spatiotemporal transcriptomic characteristics of immune and metabolic dysregulation during mouse brain aging.

Spatiotemporal transcriptomic characteristics of immune and metabolic dysregulation during mouse brain aging.

Journal: Journal of translational medicine

Published: May 10, 2025

NUF2 activated by YY1 promotes prostate cancer malignancy via p38/MAPK signaling axis and serves as a therapeutic target.

NUF2 activated by YY1 promotes prostate cancer malignancy via p38/MAPK signaling axis and serves as a therapeutic target.

Journal: Biochemical pharmacology

Published: December 09, 2024

Interplay of RNA m6A Modification-Related Geneset in Pan-Cancer.

Interplay of RNA m6A Modification-Related Geneset in Pan-Cancer.

Journal: Biomedicines

Published: May 31, 2024

EMP3 as a key downstream target of miR-663a regulation interferes with MAPK/ERK signaling pathway to inhibit gallbladder cancer progression.

EMP3 as a key downstream target of miR-663a regulation interferes with MAPK/ERK signaling pathway to inhibit gallbladder cancer progression.

Journal: Cancer letters

Published: July 30, 2023

Comparison of diagnostic performance of Clear Cell Likelihood Score v1.0 and v2.0 for clear renal cell carcinoma

Comparison of diagnostic performance of Clear Cell Likelihood Score v1.0 and v2.0 for clear renal cell carcinoma

Journal: Nan fang yi ke da xue xue bao = Journal of Southern Medical University

Published: June 14, 2023

Retraction notice to "EMP3, which is regulated by miR-663a, suppresses gallbladder cancer progression via interference with the MAPK/ERK pathway" [Canc. Lett. 430 (2018) 97-108].

Retraction notice to "EMP3, which is regulated by miR-663a, suppresses gallbladder cancer progression via interference with the MAPK/ERK pathway" [Canc. Lett. 430 (2018) 97-108].

Journal: Cancer letters

Published: October 10, 2022

Showing 1-12 of 42

Last Updated: 09/26/2026